Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoma, B-Cell × blinatumomab × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 16 Leukemia 8 Burkitt Lymphoma 8 Recurrence 7 Lymphoproliferative Disorders 6 Lymphatic Diseases 5 Lymphoma, Non-Hodgkin 4 Immunoproliferative Disorders 4 Neoplasm, Residual 3 Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Leukemia, Lymphoid 2 Neoplasms by Histologic Type 1 Myelodysplastic Syndromes 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Large Granular Lymphocytic 1 Leukemia, Biphenotypic, Acute 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Bites and Stings 1

Interventions

Rituximab 34 Cyclophosphamide 24 Etoposide 12 Doxorubicin 12 Vincristine 11 Prednisone 11 ibrutinib 9 fludarabine 8 fludarabine phosphate 7 Mycophenolic Acid 5 Inotuzumab Ozogamicin 5 Cytarabine 5 pembrolizumab 4 Peripheral Blood Stem Cell Transplantation 4 Lenalidomide 4 Carmustine 4 CT-P10 4 Brentuximab Vedotin 4 Bortezomib 4 tositumomab I-131 3 tazemetostat 3 obinutuzumab 3 Prednisolone 3 Methylprednisolone 3 Melphalan 3 Ifosfamide 3 Granulocyte Colony-Stimulating Factor 3 Filgrastim 3 Diphenhydramine 3 Cyclosporine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡